PHAXIAM Therapeutics (NASDAQ:PHXM – Get Free Report) and Agenus (NASDAQ:AGEN – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations and risk. Analyst Recommendations This is a breakdown of current […]
PHAXIAM Therapeutics S.A. (NASDAQ:PHXM – Free Report) shares are going to reverse split before the market opens on Wednesday, September 20th. The 1-10 reverse split was announced on Wednesday, September 20th. The number of shares owned by shareholders will be adjusted after the closing bell on Wednesday, September 20th. PHAXIAM Therapeutics Price Performance Shares of […]
PHAXIAM Therapeutics (NASDAQ:PHXM – Get Free Report) is scheduled to announce its earnings results after the market closes on Thursday, September 21st. PHAXIAM Therapeutics Stock Performance Shares of PHAXIAM Therapeutics stock opened at $0.42 on Friday. The business has a fifty day moving average price of $0.56. The company has a quick ratio of 3.65, […]